News & Views
Biological-based medicines will be the focus of scientists
Jul 13 2011
Professor Gino Martini, a pharmacist and senior director at GlaxoSmithKline Research and Development, said that many pharmaceutical companies are struggling to replenish pipelines as many patents are coming to an end.
For this reason, scientists are turning towards diversifying business models, he explained.
"So [they are] looking at consumers, over-the-counter medicines, nutrition, medical device companies - they're looking to invest in divisions that are linked to pharmacy but not quite pharmacy," Professor Martini.
He suggested that many firms are developing biological-based medicines, such as monochrome antibodies and vaccines.
China and India are also set to become major players in global pharmaceutical research and development, he predicted.
Meanwhile, researchers from Queen Mary, University of London, have identified a molecule which is essential to the resetting of biological body clocks in fruit flies.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia